The Esc Textbook of Preventive Cardiology and the Esc Handbook of Preventive Cardiology
Herausgeber: Gielen, Stephan; Graham, Ian; Jennings, Catriona; Wood, David; Piepoli, Massimo; de Backer, Guy
The Esc Textbook of Preventive Cardiology and the Esc Handbook of Preventive Cardiology
Herausgeber: Gielen, Stephan; Graham, Ian; Jennings, Catriona; Wood, David; Piepoli, Massimo; de Backer, Guy
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Combining an accessible and practical how-to manual with a comprehensive textbook, together with full online access to both resources, this pack provides medical professionals with a great-value resource covering all aspects of preventive cardiology.
Andere Kunden interessierten sich auch für
- Nathan WongASPC Manual of Preventive Cardiology94,99 €
- Esc Handbook of Cardiovascular Rehabilitation48,99 €
- Oxford American Handbook of Cardiology97,99 €
- Daniel X AugustineEssential Revision Notes for the European Exam in Core Cardiology108,99 €
- Jeremy BrownCardiology Emergencies82,99 €
- Julian HaywoodCardiology at the Los Angeles County + Usc Medical Center: A Personalized History10,99 €
- Mark EisenbergCardiology Board Review and Self-Assessment: A Companion Guide to Hurst's the Heart105,99 €
-
-
-
Combining an accessible and practical how-to manual with a comprehensive textbook, together with full online access to both resources, this pack provides medical professionals with a great-value resource covering all aspects of preventive cardiology.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press, USA
- Seitenzahl: 616
- Erscheinungstermin: 15. November 2016
- Englisch
- Abmessung: 226mm x 282mm x 33mm
- Gewicht: 1512g
- ISBN-13: 9780198795049
- ISBN-10: 0198795041
- Artikelnr.: 54438972
- Verlag: Oxford University Press, USA
- Seitenzahl: 616
- Erscheinungstermin: 15. November 2016
- Englisch
- Abmessung: 226mm x 282mm x 33mm
- Gewicht: 1512g
- ISBN-13: 9780198795049
- ISBN-10: 0198795041
- Artikelnr.: 54438972
Stephan Gielen is the Deputy Director & Head of Department of the University Clinic & Clinic for Internal Medicine III in Halle (Saale), Germany. He was President of the European Association of Preventive Cardiology (EAPC) from 2012-2014, and is Speaker of the Working Group of Preventive Cardiology of the German Society of Cardiology, and Vice Speaker of the Working Group on Cardiac Diseases in the Elderly. After his medical education at the University of Bochum, Germany, Harvard Medical School, Boston, and Baylor College of Medicine, Houston, USA, he started his internship at Heidelberg University before moving to Leipzig in 1997. Guy De Backer graduated as medical doctor at Ghent University in 1968. He holds a special degree in cardiology and in cardiac rehabilitation and he was awarded with an additional degree in public health. From 1973 until 1988 he was a permanent research fellow at the National Fund for Scientific Research (Belgium). In 1979 he was awarded with a PhD in epidemiology at Ghent University. From 1988 onwards he was professor of medicine at Ghent University chairing the Department of Public Health from 1989-2009 and the Cardiac Rehabilitation center of the University Hospital from 1983-2009. He is the author or co-author of more than 405 publications in journals cited in SCI, SSCI or AHCI, 120 papers in other journals and more than 40 chapters in books. Guy De Backer is a member and the past-chairman of the Superior Health Council in Belgium (1996-2009) and a member and the past-president of the Royal Academy of Medicine of Belgium (2007-2010). Professor Massimo F Piepoli is a Honorary Clinical Senior Lecturer at Imperial College. David Wood is the Garfield Weston Professor of Cardiovascular Medicine at the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, and Honorary Consultant Cardiologist to Imperial College Healthcare NHS Trust. With a special interest in prevention of cardiovascular disease (CVD), Professor Wood has developed Guidelines on CVD prevention for the World Health Organisation, European Society of Cardiology and the British Cardiovascular Society. He has contributed to policy development through the European Heart Health Initiative, leading to the St Valentines Day declaration on CVD Prevention, and subsequently the European Heart Health Charter, which aims to reduce the burden of cardiovascular disease through political advocacy. Catriona Jennings is a cardiac specialist nurse and the European Research Nurse coordinator for EUROACTION and EUROASPIRE III in the Department of Cardiovascular Medicine at the National Heart and Lung Institute, Imperial College London. Ian Graham qualified in medicine at Trinity College, Dublin. He trained in the Adelaide and St. Vincent's Hospitals in Dublin, and at Papworth Hospital in Cambridge, England. He held the post of MRC Research Fellow and, later, Director of Research at St. Vincent's Hospital and was also Director of Research at the Irish Heart Foundation. He is past president of the Irish Heart Foundation, the Irish Hyperlipidaemia Association, and of the Dublin University Biological Association. He also founded the Irish Cardiac Surgery Register. Awards and distinctions have included a Medical Research Council Fellowship, an ISFC Cardiovascular Epidemiology Fellowship, the first Stokes Lectureship in Dublin and an EU Travelling Fellowship at Erasmus University in Rotterdam, and Fellowships of the European Society of Cardiology and of the American College of Chest Physicians. He is an honorary Fellow of Trinity College, Dublin, Ireland.
* The ESC Textbook of Preventive Cardiology
* 1: EPIDEMIOLOGY OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
* 1.1: Simon Capewell, Torben Jorgensen, Susanna Sans and Martin
O'Flaherty: Scope of the problem; the potential of prevention;
prevention pays off
* 2: ETIOLOGY AND PATHOPHYSIOLOGY OF ATHEROSCLEROSIS
* 2.1: Daniel Teupser: Interaction RF: Genetic background
* 2.2: Ulf Landmesser and Wolfgang Koenig 2.3: From risk factors to
plaque development
* 2.3: Marco Cattaneo and Ekean M. Faioni: The role of thrombosis
* 3: RISK STRATIFICATION AND RISK ASSESSMENT
* 3.1: Ian Graham, Theresa Cooney and Dirk de Bacquer: Ian Graham,
Theresa Cooney and Dirk de Bacquer
* 3.2: Uwe Nixdorff, Pompillio Faggiano, Eike Nagel, Stephan Achenbach,
Jose Zamorano and Sara Fernandez: Imaging in cardiovascular
prevention
* 3.3: Diego Vannuzzo and Simona Giampaoli: Primary prevention:
Principles and practice
* 3.4: Massimo Pieopoli, Helmut Gohike and Pantaleo Giannuzzi:
Secondary prevention and cardiac rehabilitation: Principles and
practice
* 3.5: Christian Albus and Christoph Hermann-Lingen: Behaviour and
motivation
* 3.6: Charlotta Pisinger and Serena Tonstad: Smoking
* 3.7: Jean Dallongeville, Monique Verscheuren and Deborah Lycett:
Nutrition (nutriceuticals, functional food, supplements, alcohol,
polymeal)
* 3.8: Stephan Gielen, Alassandro Mezzani, Dabiel Forman, Joseph
Niebauer and Lucien Vanhees: Physical inactivity and activity
* 3.9: Gabriele Riccardi: Overweight, obestity and central obesity
* 3.10: Robert Fagard, Renata Cifkova and Guiseppe Mancia: Blood
pressure
* 3.11: Zeljko Reienr, Olov Wiklund and John Betteridge: Lipids
* 3.12: Jaako Tuomilehto, Andre Scheen and Lars Ryden: Glucose
intolerance and diabetes
* 3.13: Kurt Huber and Joao Morais: Coagulation and thrombosis
* 3.14: Thores Thoerell and Chantal Brisson: Psychosocial factors
* 3.15: Johan DeSutter, Miguel Mendes and Oscar Franco:
Cardioprotective drugs
* 4: SETTING AND DELIVERY OF PREVENTIVE CARDIOLOGY
* 4.1: Pantaleo Giannuzzi: General remarks
* 4.2: Ugo Corra and Bernard Rauch: Immediate secondary prevention and
referral
* 4.3: Heinz Voller, Jean-Paul Schmid and Bernard Schwaab:
Hospital-based rehabilitation units
* 4.4: Jean Paul Schmid and Hugo Sanner: Ambulatory preventive care
* 4.5: Emer Shelley and Margaret Cupples: Health promotion for the
general public
* 4.6: Susan Connolly and Margaret Cupples: Community-based prevention
centres
* 5: EVALUATION OF PREVENTIVE CARDIOLOGY
* 5.1: Kornelia Kotseva, Massimo Piepoli and Neil Oldridge: Measuring
quality of care
* The ESC Handbook of Preventive Cardiology
* 1: WHAT IS PREVENTION AND WHY DO WE NEED IT?
* 2: WHO SHOULD BENEFIT FROM PREVENTION?
* 2.1: What is a high risk patient?
* 2.2: How to assess risk
* 2.3: Biomarkers in risk assessment
* 2.4: Imaging in risk assessment
* 2.5: Erectile dysfunction and cardiovascular risk
* 2.6: Priorities and targets
* 3: PRACTICAL ASPECTS OF PREVENTION
* 3.1: Behavioural strategies to support and sustain lifestyle change
* 3.2: Lifestyle assessment and intervention: An overview
* 3.3: Engaging individuals, families and carers in prevention
* 3.4: Smoking cessation
* 3.5: Diet and weight: Major lifestyle challenges
* 3.6: Helping people to become more physically active
* 3.7: Blood pressure management
* 3.8: Lipid management
* 3.9: Blood glucose management
* 3.10: Drug therapies to reduce risk: Evidence and practicalities
* 3.11: Identifying and managing psychosocial factors
* 3.12: A total risk management approach: Putting it all together
* 3.13: Putting educational strategies into practice
* 4: SETTING UP PREVENTIVE CARDIOLOGY INITIATIVES
* 4.1: Practicalities (a) hospital, (b) general practice, (c) community
* 4.2: Staffing and training needs for preventive cardiology
initiatives
* 4.3: How the global care pathway works in practice
* 4.4: Overcoming barriers to prevention
* 5: QUALITY IMPROVEMENT
* 5.1: Standards and outcome measures
* 5.2: Audit: principles and examples
* 1: EPIDEMIOLOGY OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
* 1.1: Simon Capewell, Torben Jorgensen, Susanna Sans and Martin
O'Flaherty: Scope of the problem; the potential of prevention;
prevention pays off
* 2: ETIOLOGY AND PATHOPHYSIOLOGY OF ATHEROSCLEROSIS
* 2.1: Daniel Teupser: Interaction RF: Genetic background
* 2.2: Ulf Landmesser and Wolfgang Koenig 2.3: From risk factors to
plaque development
* 2.3: Marco Cattaneo and Ekean M. Faioni: The role of thrombosis
* 3: RISK STRATIFICATION AND RISK ASSESSMENT
* 3.1: Ian Graham, Theresa Cooney and Dirk de Bacquer: Ian Graham,
Theresa Cooney and Dirk de Bacquer
* 3.2: Uwe Nixdorff, Pompillio Faggiano, Eike Nagel, Stephan Achenbach,
Jose Zamorano and Sara Fernandez: Imaging in cardiovascular
prevention
* 3.3: Diego Vannuzzo and Simona Giampaoli: Primary prevention:
Principles and practice
* 3.4: Massimo Pieopoli, Helmut Gohike and Pantaleo Giannuzzi:
Secondary prevention and cardiac rehabilitation: Principles and
practice
* 3.5: Christian Albus and Christoph Hermann-Lingen: Behaviour and
motivation
* 3.6: Charlotta Pisinger and Serena Tonstad: Smoking
* 3.7: Jean Dallongeville, Monique Verscheuren and Deborah Lycett:
Nutrition (nutriceuticals, functional food, supplements, alcohol,
polymeal)
* 3.8: Stephan Gielen, Alassandro Mezzani, Dabiel Forman, Joseph
Niebauer and Lucien Vanhees: Physical inactivity and activity
* 3.9: Gabriele Riccardi: Overweight, obestity and central obesity
* 3.10: Robert Fagard, Renata Cifkova and Guiseppe Mancia: Blood
pressure
* 3.11: Zeljko Reienr, Olov Wiklund and John Betteridge: Lipids
* 3.12: Jaako Tuomilehto, Andre Scheen and Lars Ryden: Glucose
intolerance and diabetes
* 3.13: Kurt Huber and Joao Morais: Coagulation and thrombosis
* 3.14: Thores Thoerell and Chantal Brisson: Psychosocial factors
* 3.15: Johan DeSutter, Miguel Mendes and Oscar Franco:
Cardioprotective drugs
* 4: SETTING AND DELIVERY OF PREVENTIVE CARDIOLOGY
* 4.1: Pantaleo Giannuzzi: General remarks
* 4.2: Ugo Corra and Bernard Rauch: Immediate secondary prevention and
referral
* 4.3: Heinz Voller, Jean-Paul Schmid and Bernard Schwaab:
Hospital-based rehabilitation units
* 4.4: Jean Paul Schmid and Hugo Sanner: Ambulatory preventive care
* 4.5: Emer Shelley and Margaret Cupples: Health promotion for the
general public
* 4.6: Susan Connolly and Margaret Cupples: Community-based prevention
centres
* 5: EVALUATION OF PREVENTIVE CARDIOLOGY
* 5.1: Kornelia Kotseva, Massimo Piepoli and Neil Oldridge: Measuring
quality of care
* The ESC Handbook of Preventive Cardiology
* 1: WHAT IS PREVENTION AND WHY DO WE NEED IT?
* 2: WHO SHOULD BENEFIT FROM PREVENTION?
* 2.1: What is a high risk patient?
* 2.2: How to assess risk
* 2.3: Biomarkers in risk assessment
* 2.4: Imaging in risk assessment
* 2.5: Erectile dysfunction and cardiovascular risk
* 2.6: Priorities and targets
* 3: PRACTICAL ASPECTS OF PREVENTION
* 3.1: Behavioural strategies to support and sustain lifestyle change
* 3.2: Lifestyle assessment and intervention: An overview
* 3.3: Engaging individuals, families and carers in prevention
* 3.4: Smoking cessation
* 3.5: Diet and weight: Major lifestyle challenges
* 3.6: Helping people to become more physically active
* 3.7: Blood pressure management
* 3.8: Lipid management
* 3.9: Blood glucose management
* 3.10: Drug therapies to reduce risk: Evidence and practicalities
* 3.11: Identifying and managing psychosocial factors
* 3.12: A total risk management approach: Putting it all together
* 3.13: Putting educational strategies into practice
* 4: SETTING UP PREVENTIVE CARDIOLOGY INITIATIVES
* 4.1: Practicalities (a) hospital, (b) general practice, (c) community
* 4.2: Staffing and training needs for preventive cardiology
initiatives
* 4.3: How the global care pathway works in practice
* 4.4: Overcoming barriers to prevention
* 5: QUALITY IMPROVEMENT
* 5.1: Standards and outcome measures
* 5.2: Audit: principles and examples
* The ESC Textbook of Preventive Cardiology
* 1: EPIDEMIOLOGY OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
* 1.1: Simon Capewell, Torben Jorgensen, Susanna Sans and Martin
O'Flaherty: Scope of the problem; the potential of prevention;
prevention pays off
* 2: ETIOLOGY AND PATHOPHYSIOLOGY OF ATHEROSCLEROSIS
* 2.1: Daniel Teupser: Interaction RF: Genetic background
* 2.2: Ulf Landmesser and Wolfgang Koenig 2.3: From risk factors to
plaque development
* 2.3: Marco Cattaneo and Ekean M. Faioni: The role of thrombosis
* 3: RISK STRATIFICATION AND RISK ASSESSMENT
* 3.1: Ian Graham, Theresa Cooney and Dirk de Bacquer: Ian Graham,
Theresa Cooney and Dirk de Bacquer
* 3.2: Uwe Nixdorff, Pompillio Faggiano, Eike Nagel, Stephan Achenbach,
Jose Zamorano and Sara Fernandez: Imaging in cardiovascular
prevention
* 3.3: Diego Vannuzzo and Simona Giampaoli: Primary prevention:
Principles and practice
* 3.4: Massimo Pieopoli, Helmut Gohike and Pantaleo Giannuzzi:
Secondary prevention and cardiac rehabilitation: Principles and
practice
* 3.5: Christian Albus and Christoph Hermann-Lingen: Behaviour and
motivation
* 3.6: Charlotta Pisinger and Serena Tonstad: Smoking
* 3.7: Jean Dallongeville, Monique Verscheuren and Deborah Lycett:
Nutrition (nutriceuticals, functional food, supplements, alcohol,
polymeal)
* 3.8: Stephan Gielen, Alassandro Mezzani, Dabiel Forman, Joseph
Niebauer and Lucien Vanhees: Physical inactivity and activity
* 3.9: Gabriele Riccardi: Overweight, obestity and central obesity
* 3.10: Robert Fagard, Renata Cifkova and Guiseppe Mancia: Blood
pressure
* 3.11: Zeljko Reienr, Olov Wiklund and John Betteridge: Lipids
* 3.12: Jaako Tuomilehto, Andre Scheen and Lars Ryden: Glucose
intolerance and diabetes
* 3.13: Kurt Huber and Joao Morais: Coagulation and thrombosis
* 3.14: Thores Thoerell and Chantal Brisson: Psychosocial factors
* 3.15: Johan DeSutter, Miguel Mendes and Oscar Franco:
Cardioprotective drugs
* 4: SETTING AND DELIVERY OF PREVENTIVE CARDIOLOGY
* 4.1: Pantaleo Giannuzzi: General remarks
* 4.2: Ugo Corra and Bernard Rauch: Immediate secondary prevention and
referral
* 4.3: Heinz Voller, Jean-Paul Schmid and Bernard Schwaab:
Hospital-based rehabilitation units
* 4.4: Jean Paul Schmid and Hugo Sanner: Ambulatory preventive care
* 4.5: Emer Shelley and Margaret Cupples: Health promotion for the
general public
* 4.6: Susan Connolly and Margaret Cupples: Community-based prevention
centres
* 5: EVALUATION OF PREVENTIVE CARDIOLOGY
* 5.1: Kornelia Kotseva, Massimo Piepoli and Neil Oldridge: Measuring
quality of care
* The ESC Handbook of Preventive Cardiology
* 1: WHAT IS PREVENTION AND WHY DO WE NEED IT?
* 2: WHO SHOULD BENEFIT FROM PREVENTION?
* 2.1: What is a high risk patient?
* 2.2: How to assess risk
* 2.3: Biomarkers in risk assessment
* 2.4: Imaging in risk assessment
* 2.5: Erectile dysfunction and cardiovascular risk
* 2.6: Priorities and targets
* 3: PRACTICAL ASPECTS OF PREVENTION
* 3.1: Behavioural strategies to support and sustain lifestyle change
* 3.2: Lifestyle assessment and intervention: An overview
* 3.3: Engaging individuals, families and carers in prevention
* 3.4: Smoking cessation
* 3.5: Diet and weight: Major lifestyle challenges
* 3.6: Helping people to become more physically active
* 3.7: Blood pressure management
* 3.8: Lipid management
* 3.9: Blood glucose management
* 3.10: Drug therapies to reduce risk: Evidence and practicalities
* 3.11: Identifying and managing psychosocial factors
* 3.12: A total risk management approach: Putting it all together
* 3.13: Putting educational strategies into practice
* 4: SETTING UP PREVENTIVE CARDIOLOGY INITIATIVES
* 4.1: Practicalities (a) hospital, (b) general practice, (c) community
* 4.2: Staffing and training needs for preventive cardiology
initiatives
* 4.3: How the global care pathway works in practice
* 4.4: Overcoming barriers to prevention
* 5: QUALITY IMPROVEMENT
* 5.1: Standards and outcome measures
* 5.2: Audit: principles and examples
* 1: EPIDEMIOLOGY OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
* 1.1: Simon Capewell, Torben Jorgensen, Susanna Sans and Martin
O'Flaherty: Scope of the problem; the potential of prevention;
prevention pays off
* 2: ETIOLOGY AND PATHOPHYSIOLOGY OF ATHEROSCLEROSIS
* 2.1: Daniel Teupser: Interaction RF: Genetic background
* 2.2: Ulf Landmesser and Wolfgang Koenig 2.3: From risk factors to
plaque development
* 2.3: Marco Cattaneo and Ekean M. Faioni: The role of thrombosis
* 3: RISK STRATIFICATION AND RISK ASSESSMENT
* 3.1: Ian Graham, Theresa Cooney and Dirk de Bacquer: Ian Graham,
Theresa Cooney and Dirk de Bacquer
* 3.2: Uwe Nixdorff, Pompillio Faggiano, Eike Nagel, Stephan Achenbach,
Jose Zamorano and Sara Fernandez: Imaging in cardiovascular
prevention
* 3.3: Diego Vannuzzo and Simona Giampaoli: Primary prevention:
Principles and practice
* 3.4: Massimo Pieopoli, Helmut Gohike and Pantaleo Giannuzzi:
Secondary prevention and cardiac rehabilitation: Principles and
practice
* 3.5: Christian Albus and Christoph Hermann-Lingen: Behaviour and
motivation
* 3.6: Charlotta Pisinger and Serena Tonstad: Smoking
* 3.7: Jean Dallongeville, Monique Verscheuren and Deborah Lycett:
Nutrition (nutriceuticals, functional food, supplements, alcohol,
polymeal)
* 3.8: Stephan Gielen, Alassandro Mezzani, Dabiel Forman, Joseph
Niebauer and Lucien Vanhees: Physical inactivity and activity
* 3.9: Gabriele Riccardi: Overweight, obestity and central obesity
* 3.10: Robert Fagard, Renata Cifkova and Guiseppe Mancia: Blood
pressure
* 3.11: Zeljko Reienr, Olov Wiklund and John Betteridge: Lipids
* 3.12: Jaako Tuomilehto, Andre Scheen and Lars Ryden: Glucose
intolerance and diabetes
* 3.13: Kurt Huber and Joao Morais: Coagulation and thrombosis
* 3.14: Thores Thoerell and Chantal Brisson: Psychosocial factors
* 3.15: Johan DeSutter, Miguel Mendes and Oscar Franco:
Cardioprotective drugs
* 4: SETTING AND DELIVERY OF PREVENTIVE CARDIOLOGY
* 4.1: Pantaleo Giannuzzi: General remarks
* 4.2: Ugo Corra and Bernard Rauch: Immediate secondary prevention and
referral
* 4.3: Heinz Voller, Jean-Paul Schmid and Bernard Schwaab:
Hospital-based rehabilitation units
* 4.4: Jean Paul Schmid and Hugo Sanner: Ambulatory preventive care
* 4.5: Emer Shelley and Margaret Cupples: Health promotion for the
general public
* 4.6: Susan Connolly and Margaret Cupples: Community-based prevention
centres
* 5: EVALUATION OF PREVENTIVE CARDIOLOGY
* 5.1: Kornelia Kotseva, Massimo Piepoli and Neil Oldridge: Measuring
quality of care
* The ESC Handbook of Preventive Cardiology
* 1: WHAT IS PREVENTION AND WHY DO WE NEED IT?
* 2: WHO SHOULD BENEFIT FROM PREVENTION?
* 2.1: What is a high risk patient?
* 2.2: How to assess risk
* 2.3: Biomarkers in risk assessment
* 2.4: Imaging in risk assessment
* 2.5: Erectile dysfunction and cardiovascular risk
* 2.6: Priorities and targets
* 3: PRACTICAL ASPECTS OF PREVENTION
* 3.1: Behavioural strategies to support and sustain lifestyle change
* 3.2: Lifestyle assessment and intervention: An overview
* 3.3: Engaging individuals, families and carers in prevention
* 3.4: Smoking cessation
* 3.5: Diet and weight: Major lifestyle challenges
* 3.6: Helping people to become more physically active
* 3.7: Blood pressure management
* 3.8: Lipid management
* 3.9: Blood glucose management
* 3.10: Drug therapies to reduce risk: Evidence and practicalities
* 3.11: Identifying and managing psychosocial factors
* 3.12: A total risk management approach: Putting it all together
* 3.13: Putting educational strategies into practice
* 4: SETTING UP PREVENTIVE CARDIOLOGY INITIATIVES
* 4.1: Practicalities (a) hospital, (b) general practice, (c) community
* 4.2: Staffing and training needs for preventive cardiology
initiatives
* 4.3: How the global care pathway works in practice
* 4.4: Overcoming barriers to prevention
* 5: QUALITY IMPROVEMENT
* 5.1: Standards and outcome measures
* 5.2: Audit: principles and examples